• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相分离控释薄膜包衣多介质中的聚合物分布与机理转变

Polymer Distribution and Mechanism Conversion in Multiple Media of Phase-Separated Controlled-Release Film-Coating.

作者信息

Chen Lu, Yang Guobao, Chu Xiaoyang, Gao Chunhong, Wang Yuli, Gong Wei, Li Zhiping, Yang Yang, Yang Meiyan, Gao Chunsheng

机构信息

State key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.

出版信息

Pharmaceutics. 2019 Feb 14;11(2):80. doi: 10.3390/pharmaceutics11020080.

DOI:10.3390/pharmaceutics11020080
PMID:30769846
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6410001/
Abstract

Phase-separated films of water-insoluble ethyl cellulose (EC) and water-soluble hydroxypropyl cellulose (HPC) can be utilized to tailor drug release from coated pellets. In the present study, the effects of HPC levels and the pH, type, ionic strength and osmolarity of the media on the release profiles of soluble metoprolol succinates from the EC/HPC-coated pellets were investigated, and the differences in drug-release kinetics in multiple media were further elucidated through the HPC leaching and swelling kinetics of the pellets, morphology (SEM) and water uptake of the free films and the interaction between the coating polymers and the media compositions. Interestingly, the drug release rate from the pellets in different media was not in agreement with the drug solubility which have a positive correlation with the drug dissolution rate based on Noyes⁻Whitney equation law. In particular, the drug release rate in acetate buffer at pH 4.5 was faster than that in other media despite the solubility of drug was relatively lower, regardless of the HPC levels. It may be attributed to the mutual effect between the EC and acetate buffer, which improved the permeability of the film. In contrast, the release of drug in HCl solution was dependent on the HPC levels. Increasing the levels of HPC increased the effects of hydrogen ions on the polymer of HPC, which resulted in a lower viscosity and strength of the gel, forming the larger size of pores in polymer films, thus increasing the drug diffused from the coating film. Further findings in phosphate buffer showed a reduction in the drug release compared to that in other media, which was only sensitive to the osmolarity rather than the HPC level and pH of the buffer. Additionally, a mathematical theory was used to better explain and understand the experimentally measured different drug release patterns. In summary, the study revealed that the effects of the media overcompensated that of the drug solubility to some extent for controlled-release of the coating polymers, and the drug release mechanism in multiple media depend on EC and HPC rather than on HPC alone, which may have a potential to facilitate the optimization of ideally film-coated formulations.

摘要

水不溶性乙基纤维素(EC)和水溶性羟丙基纤维素(HPC)的相分离膜可用于调整包衣微丸的药物释放。在本研究中,考察了HPC含量以及介质的pH值、类型、离子强度和渗透压对EC/HPC包衣微丸中可溶性琥珀酸美托洛尔释放曲线的影响,并通过微丸的HPC浸出和溶胀动力学、形态(扫描电子显微镜)、游离膜的吸水率以及包衣聚合物与介质组成之间的相互作用,进一步阐明了多种介质中药物释放动力学的差异。有趣的是,基于Noyes-Whitney方程定律,不同介质中微丸的药物释放速率与药物溶解度不一致,而药物溶解度与药物溶解速率呈正相关。特别是,尽管药物溶解度相对较低,但在pH 4.5的醋酸盐缓冲液中的药物释放速率比其他介质中的快,且与HPC含量无关。这可能归因于EC与醋酸盐缓冲液之间的相互作用,提高了膜的渗透性。相反,HCl溶液中药物的释放取决于HPC含量。增加HPC含量会增加氢离子对HPC聚合物的作用,导致凝胶的粘度和强度降低,在聚合物膜中形成更大尺寸的孔隙,从而增加药物从包衣膜中的扩散。在磷酸盐缓冲液中的进一步研究结果表明,与其他介质相比,药物释放减少,这仅对渗透压敏感,而对缓冲液的HPC含量和pH值不敏感。此外,还使用了一种数学理论来更好地解释和理解实验测量的不同药物释放模式。总之,该研究表明,介质的影响在一定程度上对包衣聚合物的控释作用超过了药物溶解度的影响,多种介质中的药物释放机制取决于EC和HPC,而不仅仅取决于HPC,这可能有助于优化理想的薄膜包衣制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/e3006ceeba33/pharmaceutics-11-00080-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/376227d1d3f1/pharmaceutics-11-00080-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/6194d7b81cb7/pharmaceutics-11-00080-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/a71a63f255f9/pharmaceutics-11-00080-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/f082a0f80a61/pharmaceutics-11-00080-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/c84fda54fd66/pharmaceutics-11-00080-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/b98bd609c1b7/pharmaceutics-11-00080-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/72ac99e23674/pharmaceutics-11-00080-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/3349d412b4c5/pharmaceutics-11-00080-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/94a51bba25f0/pharmaceutics-11-00080-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/e20e41254c58/pharmaceutics-11-00080-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/b93da58df24b/pharmaceutics-11-00080-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/5e603dfca126/pharmaceutics-11-00080-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/e3006ceeba33/pharmaceutics-11-00080-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/376227d1d3f1/pharmaceutics-11-00080-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/6194d7b81cb7/pharmaceutics-11-00080-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/a71a63f255f9/pharmaceutics-11-00080-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/f082a0f80a61/pharmaceutics-11-00080-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/c84fda54fd66/pharmaceutics-11-00080-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/b98bd609c1b7/pharmaceutics-11-00080-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/72ac99e23674/pharmaceutics-11-00080-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/3349d412b4c5/pharmaceutics-11-00080-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/94a51bba25f0/pharmaceutics-11-00080-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/e20e41254c58/pharmaceutics-11-00080-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/b93da58df24b/pharmaceutics-11-00080-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/5e603dfca126/pharmaceutics-11-00080-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee3/6410001/e3006ceeba33/pharmaceutics-11-00080-g013.jpg

相似文献

1
Polymer Distribution and Mechanism Conversion in Multiple Media of Phase-Separated Controlled-Release Film-Coating.相分离控释薄膜包衣多介质中的聚合物分布与机理转变
Pharmaceutics. 2019 Feb 14;11(2):80. doi: 10.3390/pharmaceutics11020080.
2
New insights on how to adjust the release profile from coated pellets by varying the molecular weight of ethyl cellulose in the coating film.通过改变包衣膜中乙基纤维素的分子量来调整包衣微丸释放曲线的新见解。
Int J Pharm. 2013 Dec 15;458(1):218-23. doi: 10.1016/j.ijpharm.2013.09.016. Epub 2013 Sep 25.
3
Polymer leaching from film coating: effects on the coating transport properties.聚合物从薄膜包衣中的浸出:对包衣传递性质的影响。
Int J Pharm. 2011 Jun 15;411(1-2):43-8. doi: 10.1016/j.ijpharm.2011.03.022. Epub 2011 Mar 21.
4
Blends of enteric and GIT-insoluble polymers used for film coating: physicochemical characterization and drug release patterns.用于薄膜包衣的肠溶和胃肠道不溶性聚合物共混物:物理化学表征和药物释放模式
J Control Release. 2003 May 20;89(3):457-71. doi: 10.1016/s0168-3659(03)00155-x.
5
The influence of the molecular weight of the water-soluble polymer on phase-separated films for controlled release.水溶性聚合物分子量对用于控释的相分离膜的影响。
Int J Pharm. 2016 Sep 10;511(1):223-235. doi: 10.1016/j.ijpharm.2016.06.058. Epub 2016 Jun 24.
6
Development of terbutaline sulfate sustained-release coated pellets.硫酸特布他林缓释包衣微丸的研制
Drug Dev Ind Pharm. 1999 Apr;25(4):477-91. doi: 10.1081/ddc-100102198.
7
Coated formulations: new insights into the release mechanism and changes in the film properties with a novel release cell.包衣制剂:使用新型释放池对释放机制及薄膜性质变化的新见解
J Control Release. 2009 Jun 19;136(3):206-12. doi: 10.1016/j.jconrel.2009.02.017. Epub 2009 Feb 27.
8
Effects of molecular weight on permeability and microstructure of mixed ethyl-hydroxypropyl-cellulose films.分子量对混合乙基-羟丙基纤维素膜渗透性能和微观结构的影响。
Eur J Pharm Sci. 2013 Jan 23;48(1-2):240-8. doi: 10.1016/j.ejps.2012.11.003. Epub 2012 Nov 16.
9
New insights on the influence of manufacturing conditions and molecular weight on phase-separated films intended for controlled release.关于制造条件和分子量对用于控制释放的相分离膜的影响的新见解。
Int J Pharm. 2018 Jan 30;536(1):261-271. doi: 10.1016/j.ijpharm.2017.10.012. Epub 2017 Nov 20.
10
Blends of aqueous polymer dispersions used for pellet coating: importance of the particle size.用于微丸包衣的水性聚合物分散体混合物:粒径的重要性。
J Control Release. 2005 Jul 20;105(3):226-39. doi: 10.1016/j.jconrel.2005.03.028.

引用本文的文献

1
Engineering the Morphostructural Properties and Drug Loading Degree of Organic-Inorganic Fluorouracil-MgAl LDH Nanohybrids by Rational Control of Hydrothermal Treatment.通过水热处理的合理控制来调控有机-无机氟尿嘧啶-MgAl层状双氢氧化物纳米杂化物的形态结构性质和载药程度
ACS Omega. 2023 Jul 12;8(29):26102-26121. doi: 10.1021/acsomega.3c02288. eCollection 2023 Jul 25.
2
Ethyl cellulose coated sustained release aspirin spherules for treating COVID-19: DOE led rapid optimization using arbitrary interface; applicable for emergency situations.用于治疗 COVID-19 的乙基纤维素包衣控释阿司匹林丸:使用任意界面进行 DOE 引导的快速优化;适用于紧急情况。
Int J Biol Macromol. 2021 Jul 1;182:1769-1784. doi: 10.1016/j.ijbiomac.2021.05.156. Epub 2021 May 26.

本文引用的文献

1
When drugs plasticize film coatings: Unusual formulation effects observed with metoprolol and Eudragit RS.当药物使薄膜包衣增塑时:观察到美托洛尔和 Eudragit RS 的不同寻常的制剂效应。
Int J Pharm. 2018 Mar 25;539(1-2):39-49. doi: 10.1016/j.ijpharm.2018.01.014. Epub 2018 Jan 11.
2
Determination of the release mechanism of Theophylline from pellets coated with Surelease-A water dispersion of ethyl cellulose.测定茶碱从用Surelease(乙基纤维素水分散体)包衣的微丸中的释放机制。
Int J Pharm. 2017 Aug 7;528(1-2):345-353. doi: 10.1016/j.ijpharm.2017.05.073. Epub 2017 Jun 2.
3
Regenerated cellulose capsules for controlled drug delivery: Part IV. In-vitro evaluation of novel self-pore forming regenerated cellulose capsules.
用于控释给药的再生纤维素胶囊:第四部分。新型自造孔再生纤维素胶囊的体外评价
Eur J Pharm Sci. 2017 Jan 15;97:227-236. doi: 10.1016/j.ejps.2016.11.027. Epub 2016 Dec 2.
4
Importance of air bubbles in the core of coated pellets: Synchrotron X-ray microtomography allows for new insights.包衣丸芯中气泡的重要性:同步加速器 X 射线微断层摄影术提供了新的见解。
J Control Release. 2016 Sep 10;237:125-37. doi: 10.1016/j.jconrel.2016.06.041. Epub 2016 Jul 1.
5
The influence of the molecular weight of the water-soluble polymer on phase-separated films for controlled release.水溶性聚合物分子量对用于控释的相分离膜的影响。
Int J Pharm. 2016 Sep 10;511(1):223-235. doi: 10.1016/j.ijpharm.2016.06.058. Epub 2016 Jun 24.
6
Characterization of pore structure of polymer blended films used for controlled drug release.用于控制药物释放的聚合物共混膜的孔结构表征。
J Control Release. 2016 Jan 28;222:151-8. doi: 10.1016/j.jconrel.2015.12.011. Epub 2015 Dec 11.
7
Novel ethylcellulose-coated pellets for controlled release of metoprolol succinate without lag phase: characterization, optimization and in vivo evaluation.用于琥珀酸美托洛尔控释且无滞后相的新型乙基纤维素包衣微丸:表征、优化及体内评价
Drug Dev Ind Pharm. 2015;41(7):1120-9. doi: 10.3109/03639045.2014.931969. Epub 2014 Jul 1.
8
Application of ethylcellulose coating to hydrophilic matrices: a strategy to modulate drug release profile and reduce drug release variability.乙基纤维素包衣在亲水性基质中的应用:一种调节药物释放曲线并降低药物释放变异性的策略。
AAPS PharmSciTech. 2014 Oct;15(5):1049-59. doi: 10.1208/s12249-014-0128-5. Epub 2014 May 22.
9
Effects of polyvinylpyrrolidone both as a binder and pore-former on the release of sparingly water-soluble topiramate from ethylcellulose coated pellets.作为黏合剂和致孔剂的聚乙烯吡咯烷酮对乙基纤维素包衣微丸中难溶性托吡酯释放的影响。
Int J Pharm. 2014 Apr 25;465(1-2):187-96. doi: 10.1016/j.ijpharm.2014.02.021. Epub 2014 Feb 13.
10
New insights on how to adjust the release profile from coated pellets by varying the molecular weight of ethyl cellulose in the coating film.通过改变包衣膜中乙基纤维素的分子量来调整包衣微丸释放曲线的新见解。
Int J Pharm. 2013 Dec 15;458(1):218-23. doi: 10.1016/j.ijpharm.2013.09.016. Epub 2013 Sep 25.